ArticleOncotarget2016

NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.

Clarissa Ribeiro Reily Rocha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.